Treatment of systemic lupus erythematosus: Analysis of treatment patterns in adult and paediatric patients across four European countries.
Du M. et al, (2024), Eur j intern med
Incident Use of Hydroxychloroquine for the Treatment of Rheumatoid Arthritis and Systemic Lupus Erythematosus During the COVID-19 Pandemic.
Mercadé-Besora N. et al, (2024), Arthritis care res (hoboken), 76, 1173 - 1178
DARWIN EU®-Trends of Prescription Opioid Use in Europe
Xie J. et al, (2024), Pharmacoepidemiology and drug safety, 33, 57 - 57
Treatment of Systemic Lupus Erythematosus: Analysis of Treatment Patterns in Adult and Paediatric Patients Across Four European Countries
Du M. et al, (2024), Pharmacoepidemiology and drug safety, 33, 681 - 682
IncidencePrevalence: An R package to calculate population-level incidence rates and prevalence using the OMOP common data model.
Raventós B. et al, (2023), Pharmacoepidemiol drug saf
Agreement of COVID-19 incidence between the authoritative data and real-world evidence in England
Li X. et al, (2023), Pharmacoepidemiology and drug safety, 32, 442 - 442
Bespoke code versus off-the-shelf R package in calculating incidence rates using real-world data
Li X. et al, (2023), Pharmacoepidemiology and drug safety, 32, 417 - 418
Causal forests versus inverse probability weighting for addressing cluster-level confounding in medical device and surgical epidemiology: A simulation study
Du M. et al, (2023), Pharmacoepidemiology and drug safety, 32, 309 - 309
Propensity score estimation strategies for inclusion of surgeon confounders under different surgeon impact on treatment allocation for medical device epidemiology: A simulation study
Du M. et al, (2022), Pharmacoepidemiology and drug safety, 31, 433 - 433
The performance of different strategies to manage confounding in cardinality matching for medical device epidemiology: A simulation study
Du M. et al, (2021), Pharmacoepidemiology and drug safety, 30, 37 - 38
Special Issue: Abstracts of the 36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Virtual, September 16-17, 2020.
(2020), Pharmacoepidemiol drug saf, 29 Suppl 3, 3 - 649
Random effects modelling compared to logistic regression for treatment effect estimation in medical device safety: A simulation study
Du M. et al, (2020), Pharmacoepidemiology and drug safety, 29, 364 - 364
Random effects modelling vs logistic regression for the inclusion of surgeon covariates in propensity scores for medical device epidemiology: A simulation study
Du M. et al, (2020), Pharmacoepidemiology and drug safety, 29, 364 - 365
The impact of including surgeon covariates in propensity score estimation in medical device epidemiology: A simulation study
Du M. et al, (2020), Pharmacoepidemiology and drug safety, 29, 365 - 365